Position in XENE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$41,608,682
+$34,323,147 QoQ
Shares Held
689,342
+324.1% QoQ
Ownership
0.712%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#36
of 314 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. XENE ranks #22 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in XENE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,608,682 | 689,342 | Shares | Other | 2026-08-13 | |
| 2025-12-31 | $7,285,535 | 162,551 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $24,571,077 | 611,982 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $31,933,950 | 1,020,254 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $25,435,764 | 758,145 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $35,268,945 | 899,718 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $47,066,047 | 1,195,480 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $53,988,439 | 1,384,674 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $62,437,223 | 1,450,342 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $70,409,526 | 1,528,648 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $73,594,098 | 2,154,394 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $89,336,131 | 2,320,419 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $83,053,772 | 2,320,586 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $93,298,398 | 2,366,178 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $101,480,528 | 2,811,095 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $60,547,116 | 1,990,372 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $46,896,153 | 1,534,058 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $38,142,696 | 1,220,957 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $455,389 | 29,803 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $194,634 | 10,453 | Shares | Sole | 2021-08-13 | |
| 2020-09-30 | $413,409 | 37,345 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,039,716 | 82,912 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||